Annovis Bio Inc. (ANVS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Annovis Bio Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1.02
+2.00% today
Market cap
$43M
Overall quality
50/100
Kronos AI 30-day
+41.8%
8 of 8 simulated paths end higher
Annovis Bio Inc. (ANVS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $43M. It trades at $1.02, up 2.00% today. Its overall quality score is 50 out of 100, ranked against the whole US market. 3 analysts' average target of $10.67 implies +946.1% from today's price. Kronos AI's 30-day forecast is +41.8% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $10.67 |
| Low – high | $7.00 – $17.00 |
| Analysts | 3 |
| Upside to average | +946.1% |
Kronos AI 30-day forecast
| Expected close | $1.42 (+41.8%) |
| Likely range | +39.1% … +52.2% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 34 |
| Solvency | 75 |
| Growth | 40 |
| Overall | 50 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.